Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
Lauren L Levy*, Shayna M Solomon*, Jason J Emer Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA*Both authors contributed equally to this work and represent co-first authorshipAbstract: Elucidation of the immunopathogenesis of psoriasis has led to the discovery of novel b...
Guardado en:
Autores principales: | Levy LL, Solomon SM, Emer JJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b88dbb1a60aa491da0adb230dd5695a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014) -
Long-term safety of biologics in the treatment of psoriasis
por: Panchal MR, et al.
Publicado: (2013) -
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016) -
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
por: Chiricozzi A, et al.
Publicado: (2019) -
Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
por: Molteni S, et al.
Publicado: (2012)